Seagate Guides Q4 In Line With Estimates - Update

While reporting financial results for the third quarter on Wednesday, data storage maker Seagate Technology Holdings plc (STX) provided revenue and earnings guidance for its fiscal fourth quarter, in line with analysts' estimates.

For the fourth quarter, the company now projects adjusted earnings in a range of $1.70 to $2.10 per share on revenues between $2.65 billion and $2.95 billion.

On average, 11 analysts polled by Thomson Reuters expect the company to report earnings of $2.05 per share on revenues of $2.91 billion for the quarter. Analysts' estimates typically exclude special items.

The Board of Directors of the Company also declared a quarterly cash dividend of $0.70 per share, which will be payable on July 7, 2022 to shareholders of record as of the close of business on June 24, 2022.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Covid vaccine makers Pfizer Inc. and BioNTech SE announced a new $3.2 billion vaccine supply deal with the U.S. Government, as the country is bracing for a Covid outbreak this fall. Under the deal, the U.S. government will receive 105 million doses (30 µg, 10 µg and 3 µg) of Pfizer -BioNTech covid vaccines initially. The order may include adult Omicron-adapted COVID-19 vaccines. Samsung Electronics Co. has started the initial mass production of 3-nanometer or nm chips, which is considered as the most advanced chip in the world. In its move, the South Korean tech major beats rival Taiwan Semiconductor Manufacturing Co., the world's largest chip manufacturer, which is reportedly in the process to build one. Bryant Ranch Prepack Inc. is recalling certain Morphine Sulfate Extended-Release Tablets citing incorrect labeling, the U.S. Food and Drug Administration said. The recall involves one lot of Morphine Sulfate 30 mg Extended-Release tablets, and one lot of Morphine Sulfate 60 mg Extended-Release tablets to the consumer level.
Follow RTT